The genus Valeriana L.: ethnopharmacology, phytochemistry and biological activities—an updated review
Cansel Çelik,
No information about this author
Hasan Kırmızıbekmez
No information about this author
Phytochemistry Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 12, 2025
Abstract
The
genus
Valeriana
L.
is
a
large
with
its
436
accepted
species
distributed
all
over
the
world.
Some
members
of
have
been
utilized
in
different
folk
medicines
to
cure
many
diseases
especially
anxiety,
sleep
disorders
and
epilepsy
since
remote
times.
Pharmacological
studies
on
extracts
prepared
mostly
from
below
ground
parts
some
mainly
V.
officinalis
,
jatamansi
V
.
amurensis
revealed
their
diverse
bioactivities
including,
anxiolytic,
antidepressant,
anticonvulsant,
anti-inflammatory,
cytotoxic,
anticancer
activities.
Many
secondary
metabolites
isolated
characterized
several
that
belong
iridoid,
sesquiterpene,
lignan,
flavonoid
chemical
classes.
Bioactivity
iridoids,
sesquiterpenes,
lignans
derived
these
possess
significant
biological
activities
such
as
anticancer,
neuroprotective,
antiviral
This
comprehensive
review
aims
provide
an
overview
traditional
use
phytochemical
composition
well
very
recent
species.
Recent
vitro,
vivo,
clinical
are
reviewed
discussed,
particularly
focusing
anti-viral
compounds
Among
metabolites,
seem
be
responsible
for
pharmacological
extracts.
Although
promising
results
were
reported
vitro
studies,
it
essential
perform
vivo
even
order
discover
new
potential
drug
leads
this
genus.
Language: Английский
Predicting immune status and gene mutations in stomach adenocarcinoma patients based on inflammatory response-related prognostic features
Huanjun Li,
No information about this author
Jingtang Chen,
No information about this author
Zhiliang Chen
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 9, 2025
Stomach
adenocarcinoma
(STAD)
is
an
aggressive
malignant
tumor.
Herein,
we
characterized
the
prognosis
based
on
inflammatory
response-related
features
and
evaluated
their
potential
impact
survival
immune
status
of
STAD
patients.
Inflammation-related
genes
obtained
from
public
databases
were
used
to
analyze
response
scores
samples.
The
differentially
expressed
(DEGs)
between
adjacent
gastric
tissue
then
analyzed
using
"limma"
package.
Genes
associated
with
intersection
inflammation-related
DEGs.
key
screened
by
last
absolute
shrinkage
selection
operator
(LASSO)
Cox
stepwise
regression
analyses
construct
prognostic
models
nomograms.
tumor
dysfunction
exclusion
(TIDE)
algorithm
was
assess
differences
in
immunotherapy
high-
low-risk
groups
explore
gene
mutation
signatures
R
software
maftools
In
addition,
GSEA
predict
pathway
characteristics
different
subgroups.
Finally,
scratch
transwell
assays
performed
role
SERPINE1
cells.
We
found
that
a
high-inflammatory
group
poor
14
DEGs
out
126
identified
be
patients,
nomograms
constructed
subsequently
(SLC7A1,
CD82,
ROS1
SLC7A2)
demonstrated
good
predictive
performance
terms
STAD.
Patients
high-risk
had
higher
StromalScore
TIDE
scores.
It
also
patients
may
have
burden.
Enrichment
analysis
revealed
significant
enrichment
epithelial-mesenchymal
transition,
angiogenesis
KRAS
pathways
group.
In-vitro
experiments
showed
down-regulation
attenuated
migratory
invasive
abilities
AGS
This
study
provides
new
insights
into
prediction
for
perspective
response.
Language: Английский